Phase 2a Study of Baxdrostat in Primary Aldosteronism

A Adina F. Turcu (University of Michigan, Ann Arbor) M Mason W. Freeman (Harvard Medical School, Boston) I Irina Bancos (Mayo Clinic, Rochester, MN) A Anat Ben-Shlomo (Cedars–Sinai Medical Center, Los Angeles) O Oksana Hamidi (University of Texas Southwestern Medical Center, Dallas) A Amir H. Hamrahian (Johns Hopkins University, Baltimore) W Wenyu Huang L Lawrence S. Kirschner (Ohio State University Wexner Medical Center, Columbus) R Ramin Sam (University of California, San Francisco, San Francisco) A Ashwini Mallappa (AstraZeneca, Gaithersburg, MD) B Bonifride Tuyishimire (AstraZeneca, Gaithersburg, MD) A Aina S. Lihn (AstraZeneca, Gothenburg, Sweden) S Shira Perl (AstraZeneca, Gaithersburg, MD) M Morris J. Brown (Queen Mary University of London, London)

Article Details

Volume / Issue Vol. 393, Issue 5
Published July 31, 2025
Pages 515-518
ISSN 0028-4793
Publisher Massachusetts Medical Society

Journal Info

New England Journal of Medicine

Massachusetts Medical Society

ISSN: 0028-4793 Social Sciences

Authors (14)

A

Adina F. Turcu

University of Michigan, Ann Arbor

M

Mason W. Freeman

Harvard Medical School, Boston

I

Irina Bancos

Mayo Clinic, Rochester, MN

A

Anat Ben-Shlomo

Cedars–Sinai Medical Center, Los Angeles

O

Oksana Hamidi

University of Texas Southwestern Medical Center, Dallas

A

Amir H. Hamrahian

Johns Hopkins University, Baltimore

W

Wenyu Huang

L

Lawrence S. Kirschner

Ohio State University Wexner Medical Center, Columbus

R

Ramin Sam

University of California, San Francisco, San Francisco

A

Ashwini Mallappa

AstraZeneca, Gaithersburg, MD

B

Bonifride Tuyishimire

AstraZeneca, Gaithersburg, MD

A

Aina S. Lihn

AstraZeneca, Gothenburg, Sweden

S

Shira Perl

AstraZeneca, Gaithersburg, MD

M

Morris J. Brown

Queen Mary University of London, London